Literature DB >> 25416280

Human FMRP contains an integral tandem Agenet (Tudor) and KH motif in the amino terminal domain.

Leila K Myrick1, Hideharu Hashimoto2, Xiaodong Cheng2, Stephen T Warren3.   

Abstract

Fragile X syndrome, a common cause of intellectual disability and autism, is due to mutational silencing of the FMR1 gene leading to the absence of its gene product, fragile X mental retardation protein (FMRP). FMRP is a selective RNA binding protein owing to two central K-homology domains and a C-terminal arginine-glycine-glycine (RGG) box. However, several properties of the FMRP amino terminus are unresolved. It has been documented for over a decade that the amino terminus has the ability to bind RNA despite having no recognizable functional motifs. Moreover, the amino terminus has recently been shown to bind chromatin and influence the DNA damage response as well as function in the presynaptic space, modulating action potential duration. We report here the amino terminal crystal structures of wild-type FMRP, and a mutant (R138Q) that disrupts the amino terminus function, containing an integral tandem Agenet and discover a novel KH motif.
© The Author 2014. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25416280      PMCID: PMC4381759          DOI: 10.1093/hmg/ddu586

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  42 in total

1.  Multiparametric scaling of diffraction intensities.

Authors:  Zbyszek Otwinowski; Dominika Borek; Wladyslaw Majewski; Wladek Minor
Journal:  Acta Crystallogr A       Date:  2003-04-25       Impact factor: 2.290

Review 2.  Fragile X syndrome: loss of local mRNA regulation alters synaptic development and function.

Authors:  Gary J Bassell; Stephen T Warren
Journal:  Neuron       Date:  2008-10-23       Impact factor: 17.173

Review 3.  Molecular mechanisms of fragile X syndrome: a twenty-year perspective.

Authors:  Michael R Santoro; Steven M Bray; Stephen T Warren
Journal:  Annu Rev Pathol       Date:  2011-10-10       Impact factor: 23.472

4.  FMRP regulates neurotransmitter release and synaptic information transmission by modulating action potential duration via BK channels.

Authors:  Pan-Yue Deng; Ziv Rotman; Jay A Blundon; Yongcheol Cho; Jianmin Cui; Valeria Cavalli; Stanislav S Zakharenko; Vitaly A Klyachko
Journal:  Neuron       Date:  2013-02-20       Impact factor: 17.173

5.  Hypersensitivity to mGluR5 and ERK1/2 leads to excessive protein synthesis in the hippocampus of a mouse model of fragile X syndrome.

Authors:  Emily K Osterweil; Dilja D Krueger; Kimberly Reinhold; Mark F Bear
Journal:  J Neurosci       Date:  2010-11-17       Impact factor: 6.167

6.  Features and development of Coot.

Authors:  P Emsley; B Lohkamp; W G Scott; K Cowtan
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2010-03-24

7.  Mutational analysis establishes a critical role for the N terminus of fragile X mental retardation protein FMRP.

Authors:  Simon P Reeve; Xinda Lin; Bahar H Sahin; Fangfang Jiang; Aiyu Yao; Zhihua Liu; Hui Zhi; Kendal Broadie; Wei Li; Angela Giangrande; Bassem A Hassan; Yong Q Zhang
Journal:  J Neurosci       Date:  2008-03-19       Impact factor: 6.167

8.  FMR1 protein: conserved RNP family domains and selective RNA binding.

Authors:  C T Ashley; K D Wilkinson; D Reines; S T Warren
Journal:  Science       Date:  1993-10-22       Impact factor: 47.728

9.  Fragile X mental retardation syndrome: structure of the KH1-KH2 domains of fragile X mental retardation protein.

Authors:  Roberto Valverde; Irina Pozdnyakova; Tommi Kajander; Janani Venkatraman; Lynne Regan
Journal:  Structure       Date:  2007-09       Impact factor: 5.006

10.  BC1-FMRP interaction is modulated by 2'-O-methylation: RNA-binding activity of the tudor domain and translational regulation at synapses.

Authors:  Caroline Lacoux; Daniele Di Marino; Pietro Pilo Boyl; Francesca Zalfa; Bing Yan; Maria Teresa Ciotti; Mattia Falconi; Henning Urlaub; Tilmann Achsel; Annie Mougin; Michèle Caizergues-Ferrer; Claudia Bagni
Journal:  Nucleic Acids Res       Date:  2012-01-11       Impact factor: 16.971

View more
  49 in total

Review 1.  Altered Neuronal and Circuit Excitability in Fragile X Syndrome.

Authors:  Anis Contractor; Vitaly A Klyachko; Carlos Portera-Cailliau
Journal:  Neuron       Date:  2015-08-19       Impact factor: 17.173

Review 2.  Rare FMR1 gene mutations causing fragile X syndrome: A review.

Authors:  Adam F Sitzmann; Robert T Hagelstrom; Flora Tassone; Randi J Hagerman; Merlin G Butler
Journal:  Am J Med Genet A       Date:  2017-11-27       Impact factor: 2.802

3.  Kinase pathway inhibition restores PSD95 induction in neurons lacking fragile X mental retardation protein.

Authors:  Ying Yang; Yang Geng; Dongyun Jiang; Lin Ning; Hyung Joon Kim; Noo Li Jeon; Anthony Lau; Lu Chen; Michael Z Lin
Journal:  Proc Natl Acad Sci U S A       Date:  2019-05-22       Impact factor: 11.205

4.  The Tudor SND1 protein is an m6A RNA reader essential for replication of Kaposi's sarcoma-associated herpesvirus.

Authors:  Belinda Baquero-Perez; Agne Antanaviciute; Ivaylo D Yonchev; Ian M Carr; Stuart A Wilson; Adrian Whitehouse
Journal:  Elife       Date:  2019-10-24       Impact factor: 8.140

5.  RNA-Binding Specificity of the Human Fragile X Mental Retardation Protein.

Authors:  Youssi M Athar; Simpson Joseph
Journal:  J Mol Biol       Date:  2020-04-25       Impact factor: 5.469

6.  The Human Fragile X Mental Retardation Protein Inhibits the Elongation Step of Translation through Its RGG and C-Terminal Domains.

Authors:  Youssi M Athar; Simpson Joseph
Journal:  Biochemistry       Date:  2020-09-29       Impact factor: 3.162

7.  Crystal structure reveals specific recognition of a G-quadruplex RNA by a β-turn in the RGG motif of FMRP.

Authors:  Nikita Vasilyev; Anna Polonskaia; Jennifer C Darnell; Robert B Darnell; Dinshaw J Patel; Alexander Serganov
Journal:  Proc Natl Acad Sci U S A       Date:  2015-09-15       Impact factor: 11.205

Review 8.  Therapeutic Strategies in Fragile X Syndrome: From Bench to Bedside and Back.

Authors:  Christina Gross; Anne Hoffmann; Gary J Bassell; Elizabeth M Berry-Kravis
Journal:  Neurotherapeutics       Date:  2015-07       Impact factor: 7.620

9.  N6-methyladenosine (m6A) recruits and repels proteins to regulate mRNA homeostasis.

Authors:  Raghu R Edupuganti; Simon Geiger; Rik G H Lindeboom; Hailing Shi; Phillip J Hsu; Zhike Lu; Shuang-Yin Wang; Marijke P A Baltissen; Pascal W T C Jansen; Martin Rossa; Markus Müller; Hendrik G Stunnenberg; Chuan He; Thomas Carell; Michiel Vermeulen
Journal:  Nat Struct Mol Biol       Date:  2017-09-04       Impact factor: 15.369

Review 10.  Fragile X-related protein family: a double-edged sword in neurodevelopmental disorders and cancer.

Authors:  Mrinmoyee Majumder; Roger H Johnson; Viswanathan Palanisamy
Journal:  Crit Rev Biochem Mol Biol       Date:  2020-09-02       Impact factor: 8.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.